tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SynAct Pharma’s CFO Departure Marks New Chapter in Strategic Development
Company AnnouncementsSynAct Pharma’s CFO Departure Marks New Chapter in Strategic Development
4d ago
SynAct Pharma Enhances Shareholder Stability with Strategic Transactions
PremiumCompany Announcements
SynAct Pharma Enhances Shareholder Stability with Strategic Transactions
12d ago
SynAct Pharma Strengthens Leadership with New Chief Business Officer
PremiumCompany Announcements
SynAct Pharma Strengthens Leadership with New Chief Business Officer
15d ago
SynAct Pharma Expands Shares and Votes Following Warrant Conversion
PremiumCompany Announcements
SynAct Pharma Expands Shares and Votes Following Warrant Conversion
22d ago
SynAct Pharma AB Releases Q2 2025 Interim Report
PremiumCompany Announcements
SynAct Pharma AB Releases Q2 2025 Interim Report
1M ago
SynAct Pharma Secures SEK 17.7 Million from Warrant Conversion
PremiumCompany AnnouncementsSynAct Pharma Secures SEK 17.7 Million from Warrant Conversion
1M ago
SynAct Pharma Expands Share Base and Strengthens Financial Position
Premium
Company Announcements
SynAct Pharma Expands Share Base and Strengthens Financial Position
2M ago
SynAct Pharma Secures SEK 17.7 Million from Warrant Conversion
Premium
Company Announcements
SynAct Pharma Secures SEK 17.7 Million from Warrant Conversion
2M ago
SynAct Pharma Secures SEK 17.7 Million from Warrant Conversion
PremiumCompany Announcements
SynAct Pharma Secures SEK 17.7 Million from Warrant Conversion
2M ago
SynAct Pharma’s Leadership Commits to Long-Term Growth with Lock-Up Agreements
PremiumCompany Announcements
SynAct Pharma’s Leadership Commits to Long-Term Growth with Lock-Up Agreements
3M ago
SynAct Pharma AB Announces Increase in Shares and Votes
PremiumCompany Announcements
SynAct Pharma AB Announces Increase in Shares and Votes
3M ago
SynAct Pharma’s Leadership Shows Confidence with Share Acquisition
PremiumCompany Announcements
SynAct Pharma’s Leadership Shows Confidence with Share Acquisition
3M ago
SynAct Pharma Refines Strategy for Lead Compound Resomelagon
PremiumCompany AnnouncementsSynAct Pharma Refines Strategy for Lead Compound Resomelagon
4M ago
SynAct Pharma Secures SEK 37 Million in Directed Share Issue
Premium
Company Announcements
SynAct Pharma Secures SEK 37 Million in Directed Share Issue
4M ago
SynAct Pharma Secures SEK 30 Million Credit Facility to Bolster Financial Stability
Premium
Company Announcements
SynAct Pharma Secures SEK 30 Million Credit Facility to Bolster Financial Stability
4M ago
SynAct Pharma to Host Capital Markets Day in Stockholm
PremiumCompany Announcements
SynAct Pharma to Host Capital Markets Day in Stockholm
4M ago
SynAct Pharma AB Annual Meeting Highlights Key Resolutions and Strategic Authorizations
PremiumCompany Announcements
SynAct Pharma AB Annual Meeting Highlights Key Resolutions and Strategic Authorizations
4M ago
SynAct Pharma AB’s Q1 2025 Interim Report Highlights
PremiumCompany Announcements
SynAct Pharma AB’s Q1 2025 Interim Report Highlights
4M ago
SynAct Pharma Secures Extended US Patent for Resomelagon Combination Therapy
PremiumCompany Announcements
SynAct Pharma Secures Extended US Patent for Resomelagon Combination Therapy
4M ago
SynAct Pharma to Host Capital Markets Day Amidst Strategic Advancements
PremiumCompany AnnouncementsSynAct Pharma to Host Capital Markets Day Amidst Strategic Advancements
5M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >